Published in Obesity and Diabetes Week, January 19th, 2004
Since its discovery around 80 years ago, insulin dosage is traditionally standardized in "units" measurement. Coremed's Alveair pulmonary prototype features a hand-held device that delivers inhaled insulin in units, making it possible for the direct substitution of injectable insulin.
Exclusively dedicated to the development of oral insulin, Coremed, Inc., has conducted some of the most intensive preclinical biological trials of oral insulin anywhere, resulting in its published data presented at...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.